Italia markets open in 5 hours 19 minutes

Dow Jones
39.872,99
+66,22(+0,17%)
Nasdaq
16.832,62
+37,75(+0,22%)
Nikkei 225
38.673,27
-273,66(-0,70%)
EUR/USD
1,0860
+0,0001(+0,01%)
Bitcoin EUR
64.549,36
-819,41(-1,25%)
CMC Crypto 200
1.525,10
+36,56(+2,46%)

NVCR Jan 2026 15.000 put

OPR - OPR Prezzo differito. Valuta in USD.

Aggiungi a watchlist

3,3000

0,0000

(0,00%)

In data: 03:31PM EDT. Mercato aperto.

GlobeNewswire
Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival versus standard of care with no added systemic toxicities Tumor Treating Fields therapy together with immune checkpoint inhibitors resulted in an unprecedented 8-month improvement in median overall survival LUNAR is the first phase 3 clinical trial in more than seven years to show a significant extension in overall survival in